CN107260682A - A kind of ion VC powder sprays and preparation method thereof - Google Patents

A kind of ion VC powder sprays and preparation method thereof Download PDF

Info

Publication number
CN107260682A
CN107260682A CN201710402307.8A CN201710402307A CN107260682A CN 107260682 A CN107260682 A CN 107260682A CN 201710402307 A CN201710402307 A CN 201710402307A CN 107260682 A CN107260682 A CN 107260682A
Authority
CN
China
Prior art keywords
parts
ion
pharmaceutical carrier
sodium
vitamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710402307.8A
Other languages
Chinese (zh)
Inventor
黄爱强
黄爱毅
刘伟林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hall Of Fangchenggang Pharmaceutical Co Ltd
Original Assignee
Hall Of Fangchenggang Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hall Of Fangchenggang Pharmaceutical Co Ltd filed Critical Hall Of Fangchenggang Pharmaceutical Co Ltd
Priority to CN201710402307.8A priority Critical patent/CN107260682A/en
Publication of CN107260682A publication Critical patent/CN107260682A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of ion VC powder sprays and preparation method thereof, it is made up of the raw material of following weight proportion:1 100 parts of vitamine C sodium, 1 300 parts of pharmaceutical carrier, pharmaceutical carrier is:One or more in glucose, mannitol, xylitol, sucrose, stevioside, isomalt etc.;Invention formulation is to be filled with doser after fully being mixed with vitamine C sodium nano level superfine powder and pharmaceutical carrier nano level superfine powder, affected part is reached after administration in the form of being atomized medicinal powder, it can make medicine performance targeting, efficient, quick-acting, safe treatment canker sore effect simultaneously and have to be convenient to use and carry, patient compliance is good, the advantages of nonirritant to mucous membrane, atomization medicinal powder is directly fully contacted with affected part, it is uniformly distributed, absorbs rapidly in affected part and play drug effect, ion VC clinical indication scope is further expanded.

Description

A kind of ion VC powder sprays and preparation method thereof
Technical field
The invention belongs to medicine field, it is related to a kind of ion VC powder sprays and preparation method thereof.
Background technology
Increasing data shows that vitamin C treatment canker sore is evident in efficacy, can substantially shorten ulcer symptoms disappearance Time, recurrence rate is reduced, improve treatment satisfaction, and security is preferable;Clinically often tie up life using high dose intravenous Plain C is locally applied for canker sore caused by treating cancer Chemotherapy in Patients, radiotherapy later stage or by VITAMIN C TABLET grind into powder Smear or take vitamin C oral formulations.
But, because the vitamin C aqueous solution is in highly acid, hyperuricemia, gouty joint can be caused on Clinical practice Inflammation breaking-out or kidney stone etc. adverse reaction;Particularly large bolus injection stimulates blood vessel to cause in use, because concentration is higher Pain, causes adverse reaction more, so get blood vessel express developed to isotonic solution after need to being administered or be administered using deep venouspuncture, Mitigate stimulation of the Vc to blood vessel;It is also restrained in terms of drug combination, it need to as far as possible be used alone, not used with alkaline medicine 5, In order to avoid reduction potency, it is very inconvenient that this needs drug combination to bring to great difficult and complicated illness;Simultaneously as it is highly acid material, The oxidizable failure in alkaline decoction, therefore need now to match somebody with somebody when in use, keep away light and heat, more bothered in clinical practice;Vitamin C Slice lapping is into powder partial smearing or oral vitamin C oral formulations, also because ascorbic highly acid is to stomach, throat, mouth Chamber mucous membrane and tooth have certain infringement.
Vitamine C sodium(That is L-AA sodium)Effect it is identical with vitamin C, but due to being sodium salt, so performance is more It is stable, while there is no ascorbic highly acid, can simultaneously be taken with multi-medicament, better than vitamin C;Vitamine C sodium Exist after into human body with ion vc state, it is easier to be absorbed by the body, participate in internal a variety of metabolic processes of human body.
The content of the invention
For background technology problem encountered, it is an object of the invention to provide a kind of ion VC for treating canker sore Powder spray and preparation method thereof.
In order to achieve the above object, the present invention is adopted the following technical scheme that:A kind of ion VC powder sprays, it is characterised in that It is made up of the raw material of following weight proportion:1-100 parts of vitamine C sodium, 1-300 parts of pharmaceutical carrier.
As an improvement, being made up of the raw material of following weight proportion:3 parts of vitamine C sodium, 8 parts of pharmaceutical carrier.
As an improvement, being made up of the raw material of following weight proportion:89 parts of vitamine C sodium, 280 parts of pharmaceutical carrier.
As an improvement, being made up of the raw material of following weight proportion:47 parts of vitamine C sodium, adds 170 parts of pharmaceutical carrier.
Another object of the present invention is to provide a kind of preparation method of ion VC powder sprays, comprise the following steps:Dimension life Plain C sodium is respectively crushed into nanoscale fine powder with pharmaceutical carrier, and particle diameter is 1000nm-5000nm, is mixed by the method for equal increments Uniformly, it is filling in doser, pack and produce.
As an improvement, pharmaceutical carrier is:In glucose, mannitol, xylitol, sucrose, stevioside, isomalt etc. One or more.
Compared with prior art, the invention has the advantages that:Invention formulation is super with vitamine C sodium nanoscale Fine powder is filled with special doser after fully being mixed with pharmaceutical carrier nano level superfine powder, is arrived after administration in the form of being atomized medicinal powder Up to affected part, can target medicine performance,
Efficiently, quick-acting, safe treatment canker sore effect is simultaneously again with being convenient to use and carry, and patient compliance is good, to viscous The advantages of film is nonirritant, atomization medicinal powder is directly fully contacted with affected part, is uniformly distributed, is absorbed rapidly in affected part and plays medicine Effect, makes ion VC clinical indication scope further be expanded.
Embodiment
In order to be better understood from the purpose of the present invention, feature and effect etc., with reference to specific embodiment to the present invention Technical scheme be described further.
Embodiment 1
A kind of ion VC powder sprays, are made up of the raw material of following weight proportion:3 parts of vitamine C sodium, 8 parts of pharmaceutical carrier.
A kind of preparation method of ion VC powder sprays, comprises the following steps:Vitamine C sodium is respectively crushed into pharmaceutical carrier Nanoscale fine powder, particle diameter is 1000nm-5000nm, is well mixed by the method for equal increments, filling in doser, sealing Packaging is produced.
Pharmaceutical carrier is:One kind in glucose, mannitol, xylitol, sucrose, stevioside, isomalt etc. or It is several.
Embodiment 2
A kind of ion VC powder sprays, are made up of the raw material of following weight proportion:89 parts of vitamine C sodium, 280 parts of pharmaceutical carrier.
A kind of preparation method of ion VC powder sprays, comprises the following steps:Vitamine C sodium is respectively crushed into pharmaceutical carrier Nanoscale fine powder, particle diameter is 1000nm-5000nm, is well mixed by the method for equal increments, filling in doser, sealing Packaging is produced.
Pharmaceutical carrier is:One kind in glucose, mannitol, xylitol, sucrose, stevioside, isomalt etc. or It is several.
Embodiment 3
A kind of ion VC powder sprays, are made up of the raw material of following weight proportion:47 parts of vitamine C sodium, adds pharmaceutical carrier 170 Part.
A kind of preparation method of ion VC powder sprays, comprises the following steps:Vitamine C sodium is respectively crushed into pharmaceutical carrier Nanoscale fine powder, particle diameter is 1000nm-5000nm, is well mixed by the method for equal increments, filling in doser, sealing Packaging is produced.
Pharmaceutical carrier is:One kind in glucose, mannitol, xylitol, sucrose, stevioside, isomalt etc. or It is several.
Embodiment 4
A kind of ion VC powder sprays, are made up of the raw material of following weight proportion:5 parts of vitamine C sodium, 30 parts of xylitol.
A kind of preparation method of ion VC powder sprays, comprises the following steps:By 30 parts points of 5 parts of vitamine C sodium and xylitol Nano level superfine powder is not ground into, particle diameter is 1000nm-5000nm, be well mixed by the method for equal increments, it is filling in special In doser, pack and produce.
Embodiment 5
A kind of ion VC powder sprays, are made up of the raw material of following weight proportion:20 parts of isomalt, vitamine C sodium 10 Part, 10 parts of xylitol.
A kind of preparation method of ion VC powder sprays, comprises the following steps:By 20 parts of isomalt, vitamine C sodium 10 parts, 10 parts of xylitol be respectively crushed into nano level superfine powder, particle diameter is 1000nm-5000nm, by equal increments method mix Close uniform, it is filling in special doser, pack and produce.
Detailed description above is only the explanation of the preferred embodiments of the invention, non-therefore the limitation present invention the scope of the claims, So, all equivalence techniques changes with carried out by this creation description are both contained in the scope of the claims of the present invention.

Claims (6)

1. a kind of ion VC powder sprays, it is characterised in that be made up of the raw material of following weight proportion:1-100 parts of vitamine C sodium, 1-300 parts of pharmaceutical carrier.
2. a kind of VC containing ion as claimed in claim 1 granule, it is characterised in that by the raw material group of following weight proportion Into:3 parts of vitamine C sodium, 8 parts of pharmaceutical carrier.
3. a kind of ion VC powder sprays as claimed in claim 1, it is characterised in that be made up of the raw material of following weight proportion: 89 parts of vitamine C sodium, 280 parts of pharmaceutical carrier.
4. a kind of ion VC powder sprays as claimed in claim 1, it is characterised in that be made up of the raw material of following weight proportion: 47 parts of vitamine C sodium, adds 170 parts of pharmaceutical carrier.
5. a kind of ion VC powder sprays as described in Claims 1-4, it is characterised in that:Described pharmaceutical carrier is:Grape One or more in sugar, mannitol, xylitol, sucrose, stevioside, isomalt etc..
6. the preparation method of a kind of ion VC powder sprays as described in Claims 1-4, it is characterised in that comprise the following steps: Vitamine C sodium is respectively crushed into nanoscale fine powder with pharmaceutical carrier, and particle diameter is 1000nm-5000nm, by the method for equal increments It is well mixed, it is filling in doser, pack and produce.
CN201710402307.8A 2017-06-01 2017-06-01 A kind of ion VC powder sprays and preparation method thereof Pending CN107260682A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710402307.8A CN107260682A (en) 2017-06-01 2017-06-01 A kind of ion VC powder sprays and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710402307.8A CN107260682A (en) 2017-06-01 2017-06-01 A kind of ion VC powder sprays and preparation method thereof

Publications (1)

Publication Number Publication Date
CN107260682A true CN107260682A (en) 2017-10-20

Family

ID=60065787

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710402307.8A Pending CN107260682A (en) 2017-06-01 2017-06-01 A kind of ion VC powder sprays and preparation method thereof

Country Status (1)

Country Link
CN (1) CN107260682A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105832763A (en) * 2016-05-11 2016-08-10 广西圣保堂健康产业股份有限公司 Medicine composition containing sodium L-ascorbate and preparing method of medicine composition
CN106310236A (en) * 2016-08-29 2017-01-11 陈石良 Antioxidation SOD oral spray and preparing method thereof
CN106727449A (en) * 2016-12-20 2017-05-31 大连丹特生物技术有限公司 A kind of Xylitol nicotinamide spray and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105832763A (en) * 2016-05-11 2016-08-10 广西圣保堂健康产业股份有限公司 Medicine composition containing sodium L-ascorbate and preparing method of medicine composition
CN106310236A (en) * 2016-08-29 2017-01-11 陈石良 Antioxidation SOD oral spray and preparing method thereof
CN106727449A (en) * 2016-12-20 2017-05-31 大连丹特生物技术有限公司 A kind of Xylitol nicotinamide spray and preparation method thereof

Similar Documents

Publication Publication Date Title
US20180193272A1 (en) Oral delivery product
ES2717879T3 (en) Formulation of diclofenac
ES2259981T3 (en) LAXANT COMPOSITION CONTAINING SIMETICONE.
RU2650646C2 (en) Compounds for the treatment of obesity and methods of use thereof
KR20060126555A (en) Dermatologic soft gel compositions
CN109010361A (en) Calcichew D3 preparation and preparation method thereof
US20230414652A1 (en) Composition and therapy for treatment of gag reflexes
CN109453169B (en) Application of bulleyaconitine A
EP1651191B1 (en) Effervescent pharmaceutical compositions containing vitamin d, calcium and phospate and their therapeutic use
CN107260682A (en) A kind of ion VC powder sprays and preparation method thereof
CN102641286A (en) Compound omeprazole dry suspension and preparation method thereof
EA007685B1 (en) Pharmaceutical composition containing toluene sulfonamide and method of use thereof
RU2369396C2 (en) Pharmaceutical composition comprising oxoplatin, its salts and derivatives
ES2351067T3 (en) PHARMACEUTICAL COMPOSITIONS EASY TO SWALLOW, THAT DO NOT CAUSE AN UNAGRAPHABLE SENSATION IN THE MOUTH AND THAT INCLUDE PARTICLES WITH AN ACTIVE INGREDIENT.
WO2022126105A1 (en) Method and composition for treating pulmonary fibrosis
US10111903B2 (en) Delivery vehicle for therapeutic gases
CN114344380A (en) Asthma-relieving aerosol inhalation solution preparation and preparation method thereof
JP5977672B2 (en) Suspension for oral administration of ibuprofen ricinate
CN105380957A (en) Acetylcysteine gel, and preparation method and application thereof
CN101919799B (en) Novel sustained-release transdermal medicament delivery system
CN104523658B (en) Erdosteine powder inhalation and preparation method thereof
ES2968237T3 (en) Pharmaceutical compositions
JPS58152820A (en) Composition for remedying cancer
CN105412058A (en) Novel application of acetylcysteine
WO2014205030A1 (en) Pulmonary administration of rotigotine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20171020